On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...